Journals / Marmara Medical Journal / 2022 / Cilt: 35 - Sayı: 1

The role of myocardial performance index and Nt-proBNP levels as a marker of heart dysfunction in nonalcoholic cirrhotic patients

Pages
10–16
Publication Date
2022-01-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Nt-proBNP levels were correlated with the disease severity and hyperdynamic circulation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Cardiac dysfunction has been reported in both cirrhotic and alcoholic patients.
📊
Key Findings & Data:Our aim was to determine the relation of serum N-terminal pro-B-type natriuretic peptide (Nt-proBNP) levels to myocardial performance index (MPI) and disease severity in nonalcoholic cirrhotic patients.
💡
Conclusion & Impact:Nt-proBNP levels were correlated with the disease severity and hyperdynamic circulation.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Cirrhosis · Heart failure · Nt-proBNP

Abstract

Objective: Cardiac dysfunction has been reported in both cirrhotic and alcoholic patients. Our aim was to determine the relation of serum N-terminal pro-B-type natriuretic peptide (Nt-proBNP) levels to myocardial performance index (MPI) and disease severity in nonalcoholic cirrhotic patients. Patients and Methods: In this prospective study including 25 cirrhotic patients and 27 healthy controls, MPI was assessed by pulsed-wave tissue Doppler imaging (PW-TDI). The disease severity was determined by Child–Turcotte–Pugh (CTP ) and model for end-stage liver disease (MELD) scores. Results: There were no statistically significant differences in MPI levels between patients and controls (p< 0.246). Nt-proBNP levels (p< 0.0003), cardiac output (CO) (p< 0.0002), left ventricular end-systolic (LVES) volume (p< 0.031) and QT interval (p< 0.0001) increased. Left ventricular systolic function was normal in all cirrhotic patients when compared to controls. Nt-proBNP levels were positively correlated with MELD scores (p< 0.0001, r= 0.59), QT duration (p< 0.0001, r= 0.59), CO (p= 0,001, r= 0.44), right atrial (RA) area (p= 0.026, r= 0.31) and negatively correlated with diastolic BP (p= 0.015, r= -0.34). Conclusion: We conclude that in nonalcoholic cirrhotic patients, left ventricular MPI and systolic function were normal. Nt-proBNP levels were correlated with the disease severity and hyperdynamic circulation.

🔖

Cite This Article

TARHAN, S. T., ENÇ, F. Y., EREN, F., FAK, A. S., ÖZDOĞAN, O. (2022). The role of myocardial performance index and Nt-proBNP levels as a marker of heart dysfunction in nonalcoholic cirrhotic patients. Marmara Medical Journal, Cilt: 35 - Sayı: 1, 10–16. https://ajindex.com/articles/688269

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Møller S, Danielsen KV, Wiese S, Hove JD, Bendtsen F. An update on cirrhotic cardiomyopathy. Expert Rev Gastroenterol Hepatol 2019; 13: 497-505. doi: 10.1080/17474124.2019.1587293. Mirijello A, Tarli C, Vassallo GA, et al. Alcoholic cardiomyopathy: What is known and what is not known. Eur J Intern Med 2017;43: 1-5. doi: 10.1016/j.ejim.2017.06.014. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008; 21: 733-41. doi: 10.1038/ajh.2008.174. Raedle-Hurst TM, Welsch C, Forestier N, et al. Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008; 20: 865-73. doi: 10.1097/MEG.0b013e3282fb7cd0. Wong F, Siu S, Liu P, Blendis LM. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clinical Science (Lond) 2001; 101: 621-8.
  2. Abbas WA, Kasem Ahmed SM, Abdel Aal AM, et al. Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy. Turk J Gastroenterol 2016; 27: 367-74. doi: 10.5152/tjg.2016.16100. Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 2005; 20: 1115-20. doi: 10.1111/j.1440-1746.2005.03906.x. Metwaly A, Khalik AA, Nasr FM, Sabry AI, Gouda MF, Hassan M. Brain natriuretic peptide in liver cirrhosis and fatty liver: Correlation with cardiac performance. Electron Physician 2016; 8:1984-93. doi: 10.19082/1984.
  3. Shi LY, Jin R, Lin CJ, et al. B-type natriuretic peptide and cirrhosis progression. Genet Mol Res 2015; 14: 5188-96. doi: 10.4238/2015.May.18.9. Wang LK, An XF, Wu XL et al. Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis. Medicine (Baltimore) 2018; 97: e13302. doi: 10.1097/MD.0000000000013302. Pimenta J, Paulo C, Gomes A, Silva S, Rocha-Gonçalves F, Bettencourt P. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver Int 2010; 30: 1059-66. doi: 10.1111/j.1478-3231.2010.02266.x. Pellett AA, Tolar WG, Merwin DG, Kerut EK. The Tei index: m